Literature DB >> 24605011

Gender specific medicine in liver diseases: a point of view.

Marilena Durazzo1, Paola Belci1, Alessandro Collo1, Vanessa Prandi1, Erika Pistone1, Maria Martorana1, Roberto Gambino1, Simona Bo1.   

Abstract

Gender medicine focuses on the patho-physiological, clinical, prevention and treatment differences in diseases that are equally represented in men and women. The purpose of gender medicine is to ensure that each individual man and woman receives the best treatment possible based on scientific evidence. The concept of "gender" includes not only the sexual characteristics of individuals but also physiological and psychological attributes of men and women, including risk factors, protective/aggravating effects of sexual hormones and variances linked to genetics and corporal structures that explain biological and physiological differences between men and women. It is very important to consider all the biological, physiological, functional, psychological, social and cultural characteristics to provide patients with individualized disease management. Herein, we critically analyze the literature regarding gender differences for diseases and acquired conditions of the most representative hepatic pathologies: primary biliary cirrhosis, autoimmune hepatitis, primary sclerosing cholangitis, non alcoholic fatty liver disease and alcoholic liver disease, and viral chronic hepatitis B and C. The last section addresses hemochromatosis, which is a prevalent iron overload disorder in the Caucasian population. This review aims to describe data from the literature concerning viral chronic hepatitis during pregnancy, management during pregnancy and delivery, and new effective drugs for the prevention of maternal infection transmission without significant adverse effects or complications.

Entities:  

Keywords:  Alcoholic liver disease; Autoimmune hepatitis; Gender; Liver disease; Non alcoholic fatty liver disease; Primary biliary cirrhosis; Viral chronic hepatitis B; Viral chronic hepatitis C

Mesh:

Year:  2014        PMID: 24605011      PMCID: PMC3942817          DOI: 10.3748/wjg.v20.i9.2127

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  87 in total

1.  Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women.

Authors:  D Conte; M Fraquelli; D Prati; A Colucci; E Minola
Journal:  Hepatology       Date:  2000-03       Impact factor: 17.425

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

3.  Sex- or gender-specific medicine in hepatology.

Authors:  Sumiko Nagoshi
Journal:  Hepatol Res       Date:  2007-11-28       Impact factor: 4.288

4.  Genetic control of the CD4/CD8 T-cell ratio in humans.

Authors:  A Amadori; R Zamarchi; G De Silvestro; G Forza; G Cavatton; G A Danieli; M Clementi; L Chieco-Bianchi
Journal:  Nat Med       Date:  1995-12       Impact factor: 53.440

5.  Chronic hepatitis B virus (HBV) infection in pregnancy.

Authors:  Hui-Hui Tan; Hock-Foong Lui; Wan-Cheng Chow
Journal:  Hepatol Int       Date:  2008-04-12       Impact factor: 6.047

6.  Epidemiology and natural history of primary biliary cirrhosis in a US community.

Authors:  W R Kim; K D Lindor; G R Locke; T M Therneau; H A Homburger; K P Batts; B P Yawn; J L Petz; L J Melton; E R Dickson
Journal:  Gastroenterology       Date:  2000-12       Impact factor: 22.682

7.  X chromosome monosomy: a common mechanism for autoimmune diseases.

Authors:  Pietro Invernizzi; Monica Miozzo; Carlo Selmi; Luca Persani; Pier Maria Battezzati; Massimo Zuin; Simona Lucchi; Pier Luigi Meroni; Bianca Marasini; Silvana Zeni; Mitchell Watnik; Francesca R Grati; Giuseppe Simoni; M Eric Gershwin; Mauro Podda
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

8.  The relationship between iron overload, clinical symptoms, and age in 410 patients with genetic hemochromatosis.

Authors:  P C Adams; Y Deugnier; R Moirand; P Brissot
Journal:  Hepatology       Date:  1997-01       Impact factor: 17.425

Review 9.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  Richard Kahn; John Buse; Ele Ferrannini; Michael Stern
Journal:  Diabetes Care       Date:  2005-09       Impact factor: 19.112

10.  Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection.

Authors:  Xiao-Mao Li; Min-Feng Shi; Yue-Bo Yang; Zhong-Jie Shi; Hong-Ying Hou; Hui-Min Shen; Ben-Qi Teng
Journal:  World J Gastroenterol       Date:  2004-11-01       Impact factor: 5.742

View more
  11 in total

Review 1.  Primary biliary cirrhosis: Clinical and laboratory criteria for its diagnosis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Gastroenterol       Date:  2015-07-07       Impact factor: 5.742

2.  Clinical Profile, Etiology, and Treatment of Chronic Pancreatitis in North American Women: Analysis of a Large Multicenter Cohort.

Authors:  Joseph Romagnuolo; Jyothsna Talluri; Elizabeth Kennard; Bimaljit S Sandhu; Stuart Sherman; Gregory A Cote; Samer Al-Kaade; Timothy B Gardner; Andres Gelrud; Michele D Lewis; Christopher E Forsmark; Nalini M Guda; Darwin L Conwell; Peter A Banks; Thiruvengadam Muniraj; Stephen R Wisniewski; Ye Tian; C Mel Wilcox; Michelle A Anderson; Randall E Brand; Adam Slivka; David C Whitcomb; Dhiraj Yadav
Journal:  Pancreas       Date:  2016-08       Impact factor: 3.327

Review 3.  Metabolism disrupting chemicals and metabolic disorders.

Authors:  Jerrold J Heindel; Bruce Blumberg; Mathew Cave; Ronit Machtinger; Alberto Mantovani; Michelle A Mendez; Angel Nadal; Paola Palanza; Giancarlo Panzica; Robert Sargis; Laura N Vandenberg; Frederick Vom Saal
Journal:  Reprod Toxicol       Date:  2016-10-17       Impact factor: 3.143

4.  Pituitary and brain dopamine D2 receptors regulate liver gene sexual dimorphism.

Authors:  Maria Cecilia Ramirez; Ana Maria Ornstein; Guillermina Maria Luque; Maria Ines Perez Millan; Isabel Garcia-Tornadu; Marcelo Rubinstein; Damasia Becu-Villalobos
Journal:  Endocrinology       Date:  2014-12-29       Impact factor: 4.736

Review 5.  Hepatic sexual dimorphism - implications for non-alcoholic fatty liver disease.

Authors:  Philippe Lefebvre; Bart Staels
Journal:  Nat Rev Endocrinol       Date:  2021-08-20       Impact factor: 43.330

6.  Estrogen and estrogen receptors chauffeur the sex-biased autophagic action in liver.

Authors:  Sipra Mohapatra; Tapas Chakraborty; Sonoko Shimizu; Kayoko Ohta; Yoshitaka Nagahama; Kohei Ohta
Journal:  Cell Death Differ       Date:  2020-06-01       Impact factor: 15.828

7.  Prognostic Significance of the Systemic Inflammatory and Immune Balance in Alcoholic Liver Disease with a Focus on Gender-Related Differences.

Authors:  Beata Kasztelan-Szczerbińska; Agata Surdacka; Krzysztof Celiński; Jacek Roliński; Agnieszka Zwolak; Sławomir Miącz; Mariusz Szczerbiński
Journal:  PLoS One       Date:  2015-06-24       Impact factor: 3.240

8.  Gender associated effects of the ethanolic extracts of Chinese propolis on the hepatic transcriptome in ethanol-treated mice.

Authors:  Manhong Ye; Mengting Xu; Mengmeng Ding; Chao Ji; Jian Ji; Fubiao Ji; Wanhong Wei; Shengmei Yang; Bin Zhou
Journal:  Iran J Basic Med Sci       Date:  2019-10       Impact factor: 2.699

9.  Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.

Authors:  Krishnakant Saboo; Amirhossein Shamsaddini; Mihir V Iyer; Chang Hu; Andrew Fagan; Edith A Gavis; Melanie B White; Michael Fuchs; Douglas M Heuman; Masoumeh Sikaroodi; Ravishankar K Iyer; Patrick M Gillevet; Jasmohan S Bajaj
Journal:  J Hepatol       Date:  2020-07-15       Impact factor: 25.083

10.  Sex-Specific Regulation of Interferon-γ Cytotoxicity in Mouse Liver by Autophagy.

Authors:  Yang Shen; Francesca Cingolani; Shoaib Ahmad Malik; Jing Wen; Yunshan Liu; Mark J Czaja
Journal:  Hepatology       Date:  2021-08-30       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.